Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Many new names sounded as if they’d been cooked up by a medieval monk. HIV-1 would henceforth be known as Lentivirus ...

Patrizia Cavazzoni, leader of the FDA's Center for Drug Evaluation and Research, is leaving the agency on Jan. 18.

Eli Lilly is partnering with the fabled venture capital firm Andreessen Horowitz on a new fund backed with $500 million of ...

Basic public health protections help augment our national security protections,” particularly when it comes to emerging ...

This is the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and ...

Enrollment of Black and Hispanic students in medical schools dropped precipitously last year after the Supreme Court banned ...

STAT reporters discuss why a looming patent cliff could lead to more pharmaceutical deal-making and a new obesity startup.